{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:25:37Z","timestamp":1718065537694},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,10]]},"DOI":"10.7759\/cureus.62094","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T21:08:45Z","timestamp":1718053725000},"source":"Crossref","is-referenced-by-count":0,"title":["Complete Response to Pembrolizumab in Stage IV Alveolar Soft Part Sarcoma After Failure of Four Lines of Treatment: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Parisa","family":"Aijaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad A","family":"Niazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23252","article-title":"Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database","volume":"57","author":"Ferrari A","year":"2011","unstructured":"Ferrari A, Sultan I, Huang TT, et al.. Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database. Pediatr Blood Cancer. 2011, 57:943-9. 10.1002\/pbc.23252","journal-title":"Pediatr Blood Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09968-5","article-title":"Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study","volume":"22","author":"Fujiwara T","year":"2022","unstructured":"Fujiwara T, Nakata E, Kunisada T, Ozaki T, Kawai A. Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study. BMC Cancer. 2022, 22:891. 10.1186\/s12885-022-09968-5","journal-title":"BMC Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4055\/cios.2014.6.1.80","article-title":"Alveolar soft part sarcoma: clinical presentation, treatment and outcome in a series of 19 patients","volume":"6","author":"Cho YJ","year":"2014","unstructured":"Cho YJ, Kim JY. Alveolar soft part sarcoma: clinical presentation, treatment and outcome in a series of 19 patients. Clin Orthop Surg. 2014, 6:80-6. 10.4055\/cios.2014.6.1.80","journal-title":"Clin Orthop Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/ijps.IJPS_14_15","article-title":"Alveolar soft part sarcoma of the forearm","volume":"50","author":"Asokan B","year":"2017","unstructured":"Asokan B, Ramanan P, Sundararaj M, Kovarthini E. Alveolar soft part sarcoma of the forearm. Indian J Plast Surg. 2017, 50:310-3. 10.4103\/ijps.IJPS_14_15","journal-title":"Indian J Plast Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010201)91:3<585::aid-cncr1038>3.0.co;2-0","article-title":"Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution","volume":"1","author":"Portera CA","year":"2001","unstructured":"Portera CA, Ho V, Patel SR, et al.. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001, 1:585-91. 10.1002\/1097-0142(20010201)91:3&lt;585::aid-cncr1038&gt;3.0.co;2-0","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204074","article-title":"The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25","volume":"20","author":"Ladanyi M","year":"2001","unstructured":"Ladanyi M, Lui MY, Antonescu CR, et al.. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001, 20:48-57. 10.1038\/sj.onc.1204074","journal-title":"Oncogene"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay","volume":"27","author":"Argani P","year":"2003","unstructured":"Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003, 27:750-61. 10.1097\/00000478-200306000-00005","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0964-1955(95)90006-3","article-title":"Soft tissue tumors, 3rd edition, 1995: F.M. Enzinger and S.W. Weiss. Mosby, St Louis, \u00a3160","volume":"31","author":"Cawson RA","year":"1995","unstructured":"Cawson RA. Soft tissue tumors, 3rd edition, 1995: F.M. Enzinger and S.W. Weiss. Mosby, St Louis, \u00a3160. Eur J Cancer B Oral Oncol. 1995, 31:405. 10.1016\/0964-1955(95)90006-3","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2004.01966.x","article-title":"Lingual alveolar soft part sarcoma; 14 cases: novel clinical and morphological observations","volume":"45","author":"Fanburg-Smith JC","year":"2004","unstructured":"Fanburg-Smith JC, Miettinen M, Folpe AL, Weiss SW, Childers EL. Lingual alveolar soft part sarcoma; 14 cases: novel clinical and morphological observations. Histopathology. 2004, 45:526-37. 10.1111\/j.1365-2559.2004.01966.x","journal-title":"Histopathology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/907179","article-title":"Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literature","volume":"2012","author":"Ogura K","year":"2012","unstructured":"Ogura K, Beppu Y, Chuman H, et al.. Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literature.  Sarcoma. 2012, 2012:6. 10.1155\/2012\/907179","journal-title":"Sarcoma"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcma.2018.01.006","article-title":"Alveolar soft part sarcoma: clinical presentation, treatment, and outcome in a series of 13 patients","volume":"81","author":"Lin YK","year":"2018","unstructured":"Lin YK, Wu PK, Chen CF, Chen CM, Tsai SW, Chih-Hsueh Chen P, Chen WM. Alveolar soft part sarcoma: clinical presentation, treatment, and outcome in a series of 13 patients. J Chin Med Assoc. 2018, 81:735-41. 10.1016\/j.jcma.2018.01.006","journal-title":"J Chin Med Assoc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s002560000285","article-title":"Alveolar soft part sarcoma: MR and angiographic findings","volume":"29","author":"Suh JS","year":"2000","unstructured":"Suh JS, Cho J, Lee SH, et al.. Alveolar soft part sarcoma: MR and angiographic findings. Skeletal Radiol. 2000, 29:680-9. 10.1007\/s002560000285","journal-title":"Skeletal Radiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7286","article-title":"Orbital alveolar soft part sarcoma: a report of 8 cases and review of the literature","volume":"15","author":"Hei Y","year":"2018","unstructured":"Hei Y, Kang L, Yang X, et al.. Orbital alveolar soft part sarcoma: a report of 8 cases and review of the literature. Oncol Lett. 2018, 15:304-14. 10.3892\/ol.2017.7286","journal-title":"Oncol Lett"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(03)00264-8","article-title":"Chemotherapy in alveolar soft part sarcomas. What do we know?","volume":"39","author":"Reichardt P","year":"19902003","unstructured":"Reichardt P, Lindner T, Pink D, Thuss-Patience PC, Kretzschmar A, D\u00f6rken B. Chemotherapy in alveolar soft part sarcomas. What do we know?. Eur J Cancer Oxf Engl. 19902003, 39:1511-6. 10.1016\/s0959-8049(03)00264-8","journal-title":"Eur J Cancer Oxf Engl"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.04.117","article-title":"Molecular landscape in alveolar soft part sarcoma: implications for molecular targeted therapy","volume":"103","author":"Soheilifar MH","year":"2018","unstructured":"Soheilifar MH, Taheri RA, Zolfaghari Emameh R, Moshtaghian A, Kooshki H, Motie MR. Molecular landscape in alveolar soft part sarcoma: implications for molecular targeted therapy. Biomed Pharmacother. 2018, 103:889-96. 10.1016\/j.biopha.2018.04.117","journal-title":"Biomed Pharmacother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq644","article-title":"Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect","volume":"22","author":"Stacchiotti S","year":"2011","unstructured":"Stacchiotti S, Negri T, Zaffaroni N, et al.. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. Ann Oncol. 2011, 22:1682-90. 10.1093\/annonc\/mdq644","journal-title":"Ann Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv530.09","article-title":"366P Pazopanib treatment in alveolar soft part sarcomas","volume":"26","author":"Kobayashi E","year":"20151","unstructured":"Kobayashi E, Kawai A, Chuman H. 366P Pazopanib treatment in alveolar soft part sarcomas. Ann Oncol. 20151, 26:108. 10.1093\/annonc\/mdv530.09","journal-title":"Ann Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007325","article-title":"Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: a systematic review and meta-analysis of randomized controlled trials","volume":"96","author":"Hao C","year":"2017","unstructured":"Hao C, Tian J, Liu H, Li F, Niu H, Zhu B. Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017, 96:e7325. 10.1097\/MD.0000000000007325","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000571","article-title":"Treatment of metastatic, refractory alveolar soft part sarcoma: case reports and literature review of treatment options in the era of targeted therapy","volume":"38","author":"Kuo DJ","year":"2016","unstructured":"Kuo DJ, Menell JS, Glade Bender JL. Treatment of metastatic, refractory alveolar soft part sarcoma: case reports and literature review of treatment options in the era of targeted therapy. J Pediatr Hematol Oncol. 2016, 38:e169-72. 10.1097\/MPH.0000000000000571","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0301-y","article-title":"Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials","volume":"5","author":"Groisberg R","year":"2017","unstructured":"Groisberg R, Hong DS, Behrang A, et al.. Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials. J Immunother Cancer. 2017, 5:100. 10.1186\/s40425-017-0301-y","journal-title":"J Immunother Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255532-complete-response-to-pembrolizumab-in-stage-iv-alveolar-soft-part-sarcoma-after-failure-of-four-lines-of-treatment-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T21:08:49Z","timestamp":1718053729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255532-complete-response-to-pembrolizumab-in-stage-iv-alveolar-soft-part-sarcoma-after-failure-of-four-lines-of-treatment-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.62094","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,10]]}}}